NCT01149499

Valacyclovir 1000 mg Tablet Under Fasting Conditions

Randomized, 2-Way Crossover, Bioequivalence Study of Valacyclovir 1000 mg Tablet and Valtrex Following a 1 x 1000 mg Dose in Healthy Subjects Under Fasting Conditions

• Status: Completed
• Phase: Phase 1
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Teva Pharmaceuticals USA · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Accepted

Summary

The objective of this study is to compare the rate and extent of absorption of valacyclovir 1000 mg tablet (test) versus Valtrex (reference), administered as 1 x 1000 mg tablet under fasting conditions.

Conditions

• Healthy

Interventions

Type	Name	Description
DRUG	Valacyclovir	1000 mg Tablet
DRUG	Valacyclovir	1000 mg Tablet

Timeline

• Start date: 2005-01-01
• Primary completion: 2005-01-01
• Completion: 2005-01-01
• First posted: 2010-06-23
• Last updated: 2010-06-23

Locations

1 site across 1 country: United States